Skip to main content

$0.860 0.010 (1.18%)

High

$0.88

Low

$0.86

Trades

19

Turnover

$55,369

Volume

64,140
30 June 2023 at 3:08pm
Register to track PIQ and receive email alerts.
Subject
PIQ Ann: Proposed issue of Securities - PIQ

PIQ Ann: Issue of Options and Secondary Trading Notice

PIQ Ann: March 2021 Quarterly Activities Report and Appendix 4C

PIQ Ann: Proteomics files US FDA 513(g) regulatory submission

PIQ Ann: ISO 13485 certification received - Manufacturing Update

PIQ Ann: Exercise of Options

PIQ Ann: Investor Presentation

PIQ Ann: Exercise of Options

PIQ Ann: Appendix 4D and Interim Financial Report

PIQ Ann: Response to Price Query

PIQ Ann: Proteomics International seeks FDA approval for PromarkerD

PIQ Ann: Update - Proposed issue of Securities - PIQ

PIQ Ann: Issue of Options and Secondary Trading Notice

PIQ Ann: Results of Meeting

PIQ Ann: December 2020 Quarterly Activities Report and Appendix 4C

PIQ Ann: Notice of Extraordinary General Meeting/Proxy Form

PIQ Ann: Results of Meeting

PIQ Ann: AGM Investor Presentation

PIQ Ann: Middle East is next market for PromarkerD immunoassay test

PIQ Ann: PromarkerD clinical assay performance results published

PIQ Ann: Change in substantial holding - Dunlop

PIQ Ann: Change in substantial holding - Lipscombe

PIQ Ann: Proteomics receives $1.1 million in R&D tax incentive

PIQ Ann: Completion of Placement and Appendix 2A

PIQ Ann: September 2020 Quarterly Activities Report and Appendix 4C

PIQ Ann: Notice of Annual General Meeting/Proxy Form

PIQ Ann: Proteomics International raises $6m in successful Placement

PIQ Ann: Proposed issue of Securities - PIQ

PIQ Ann: Proposed issue of Securities - PIQ

PIQ Ann: Trading Halt

PIQ Ann: First distribution agreement for PromarkerD immunoassay

Register to track PIQ and receive email alerts.

Similar Companies

ADO
BPH
CTE
GSS
GTG
MEM
OSL
PAL